Err what’s $2m here or there I think you’re saying; it can be readily made up eh? So the $1 to $2m wack wont really hurt as it is not actually wasted sales money or a cost after all, isn’t it.
Didn’t Mr. Eck take up $1m in shares at 38c last month? Will he be pleased and what influence, if any, does he have on Board decisions in the face of our strong and influential CEO?
The impending Court awarded loss is only about twice the total annual sales from the 1,800 exemplary Australian pharmacies stocking Evolis with outstanding average monthly sales of $92 (1 tonic and 1 shampoo equivalent).
Sadly, we are seeing an ongoing Failure to Achieve Syndrome affecting the incumbent board and the insular, controlling management hierarchy as it has for >10 years. The prospect of any return to shareholders ( let alone recovery of red ink losses from the smashed sp evidencing no confidence in the leadership) is more elusive than every.
Curious then, with entrenched destruction of shareholder wealth, the perpetual, unquestioning support for management, in particular the CEO, of the loyalists here.
They constantly point to the blue sky of the next quarterly report, million dollar day, NM sales, big end of town investors joining the register, ‘names’ joining the Board, Pacific Edge expansion, collaboration on Midkine, cash flow positive soon etc etc , even charts to prove it, yet there is no recognition by the disciples that despite it all available to CDY this management can achieve nothing tangible from it. Shame.
The AGM should allow 2 minutes silence for some serious cogitation by those at the Board table and by any compliant shareholders attending.
Expand
